ALB and cancer: Albumin nanoparticles can be synthesized utilizing various approaches (desolvation, thermally induced aggregation, self-assembly, and albumin-bound technology), and they offer useful properties, such as passive and active targeting, controlled drug release, and bypassing cancer drug resistance mechanisms [85].